Advertisement
Organisation › Details
Claris Ventures (Group)
Claris Ventures SGR is a venture capital firm based in Italy, founded in 2019. Its first fund under management, Claris Biotech I, is focused on early-stage investments in high potential biopharma companies arisen from the Italian R&D ecosystem – both local and international. The firm identifies and supports innovation in the pharmaceutical space, investing in new companies with transformational drugs under development. It aims at the highest impact possible on highly unmet patients need, building value around strong science. Claris Ventures SGR pursuit for high potential projects involves every research center, clinical structure and company in the Italian life sciences network, whether the founding team is based in Italy or it includes Italian scientists abroad who have strong links with Italy. *
Start | 2019-07-05 existent | |
Today | Claris Ventures SGR S.p.A. | |
Industry | venture capital | |
Industry 2 | BIOTECH | |
Person | Puglisi, Pietro (Claris Ventures 201907 Managing Partner + Co-Founder) | |
Person 2 | Spedaliere, Ciro (Claris Ventures 202107 Managing Partner + Co-Founder) | |
Region | Torino (Turin) (TO) | |
Country | Italy | |
Street | 1 Via Santa Giulia | |
City | 10124 Torino (TO) | |
Tel | +39-011-3325-889 | |
Address record changed: 2021-08-04 | ||
Basic data | Employees | n. a. |
Currency | EUR | |
Annual sales | 85,000,000 (capital under management (2021) 2021-07-21) | |
* Document for »About Section«: Resalis Therapeutics S.r.l.. (2/22/23). "Press Release: Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases". Torino. | ||
Record changed: 2023-06-26 |
Advertisement
More documents for Claris Ventures (Group)
- [1] Evotec SE. (3/6/24). "Press Release: Evotec and Claris Ventures Streamline Access to Accelerate Programmes from Claris's Portfolio Companies into the Clinic". Hamburg & Turin....
- [2] Resalis Therapeutics S.r.l.. (2/22/23). "Press Release: Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases". Torino....
- [3] Resalis Therapeutics S.r.l.. (2/22/23). "Press Release: Resalis Therapeutics Raises €10 Million Series A to Complete First Clinical Trial for RES-010 in Obesity". Torino....
- [4] Claris Ventures SGR S.p.A.. (7/21/21). "Press Release: Claris Ventures Announces Final Closing – €85m ($100m) for Italian Biotech"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top